NSC |
Compound |
Enrichment |
Correlation |
NSC 691819 |
Null |
0.0238174255956147 |
0.20979766 |
NSC 704435 |
Null |
0.0238174255956147 |
0.058360708 |
NSC 706192 |
Null |
0.0238174255956147 |
0.12904023 |
NSC 710334 |
Null |
0.0238174255956147 |
0.13517063 |
NSC 725191 |
1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol |
0.0238174255956147 |
0.21950242 |
NSC 749292 |
3-methoxy-1-nitrosopyrido[3,2:4,5]pyrrolo[1,2-c][1,2,3]benzotriazine |
0.0238174255956147 |
0.46452874 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.0238174255956147 |
0.13107876 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0247979034812107 |
0.33967982 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0247979034812107 |
0.087888966 |
NSC 176328 |
Ellipticine, 6-(3-aminopropyl)-, dihydrochloride |
0.0247979034812107 |
0.1715712 |